Scottsdale TMS Therapy has expanded its interventional psychiatry offerings by introducing FDA-approved Spravato (esketamine) nasal spray treatments, providing a fast-acting option for adults with treatment-resistant depression. The clinic, located in Old Town Scottsdale, now pairs esketamine therapy with existing transcranial magnetic stimulation (TMS) protocols to address complex mood disorders more effectively.
Conventional antidepressant medications typically take four to six weeks to produce measurable therapeutic effects, a timeline that places considerable psychological burden on individuals living with treatment-resistant depression. Esketamine, by contrast, can reduce depressive symptoms within days, offering a meaningful alternative for patients who have not responded to two or more standard antidepressant trials.
Esketamine operates through a distinct mechanism, acting directly on NMDA receptors to promote neuroplasticity—the brain's capacity to form new, healthier neural connections and restore circuits involved in emotional regulation. This approach addresses the biological underpinnings of major depressive disorder at a foundational level.
"When standard medications fail to deliver remission, it is an indication that the underlying neural networks require a different mechanism of stimulation," stated a spokesperson for Scottsdale TMS Therapy. "Spravato represents a major milestone in complex mood disorder care. Because it can reduce persistent depressive symptoms and decrease suicidal ideation within days rather than weeks, it serves as an immediate lifeline that restores cognitive flexibility and prepares patients for long-term psychological stabilization."
As a tightly regulated medication, esketamine requires structured medical administration. Scottsdale TMS Therapy operates as a fully REMS-certified clinic, satisfying all applicable federal safety and monitoring standards. Under the supervision of board-certified psychiatrists and master's-level clinicians, each outpatient session includes pre-treatment health screenings, supervised self-administration, and a mandatory two-hour post-treatment observation period during which blood pressure and vital signs are continuously monitored.
This structured medical oversight is provided within a private, comfort-focused setting designed to minimize patient stress and support emotional safety. The facility features Apollo TMS chairs, private treatment rooms, an on-site cafe, and an outdoor patio. To support broad access, the clinic works with major commercial payors and accepts most insurance plans, managing the full authorization process internally.
The addition of esketamine therapy broadens the clinic's scope of advanced interventional psychiatry in an outpatient setting, offering a meaningful alternative for patients who have not responded to standard treatments. Individuals or family members seeking guidance on interventional options for severe major depressive disorder can contact the clinical admissions team at Scottsdale TMS Therapy for confidential consultations, diagnostic evaluations, and same-day insurance verification.
